A video board display's the numbers after the closing bell of the Dow Industrial Average at the New York Stock Exchange on November 8, 2017 in New York. Wall Street inched to another trifecta of record closes with the Dow finishing at its fifth straight all-time high.
Alphabet (GOOGL) doesn't seem like your typical growth stock, considering it opened at $1,030.99 this morning (Oct. 27, 2017). But Wall Street is overlooking the explosive potential our tech guru sees…
Money Morning Director of Technology & Venture Capital Research
Wall Street on Monday didn’t just cash in on one winner, or a daily double, or even a trifecta. It notched astock market-style superfecta, with all four major U.S. stock indexes — representing blue chip names, technology stocks, small caps and large-company stocks — all closing at record highs on the same day for the first time in 17years.
Top executives at United Parcel Service Inc. (NYSE: UPS) took home outrageously high compensation last year, even though the parcel carrier missed many of its performance targets, like revenue growth and total shareholder returns.
In fact, UPS said in its March filings with the U.S. Securities and Exchange Commission (SEC) its three-year performance missed targets for revenue growth,....More>>>
Benefitfocus (NASDAQ: BNFT) is a benefits management company that boasts, “A powerful data-driven platform to shop, enroll, manage and exchange benefits all in one place”. The South Carolina firm separates its solutions into those aimed at employers and those aimed at insurance companies. The stock price has fallen from a peak of $74/share in....More>>>
For some investors, they’ve created small fortunes. For others, they’ve brought nothing but misery. For all investors, though, there’s no denying the fact that biotech stocks have kept things interesting if only because they can always supply a binary even traders can treat like a coin toss. The third quarter of 2017 isn’t going to be any different.
Although several obesity drugs are now on the market, they haven’t caught on nearly as much as biopharmaceutical companies had hoped they would. Investors looking to buy obesity-drug stocks are better off finding companies that also have other products either on the market or in development.
Eisai (NASDAQOTH:ESALY), Novo Nordisk (NYSE:NVO), and Roche Holding Ltd. (NASDAQOTH:RHHBY)....More>>>
Data show that Silicon Valley darlings once again captured the interest of stock fund managers looking to cash in on the sector’s growth and dreams in the fourth quarter of 2016.
In a ranking of the 20 S&P 500 stocks that U.S. funds managing more than $1 million bought the most, tech companies took eight spots: Microsoft (NASDAQ:MSFT), Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOGL),....More>>>
WiLAN (NASDAQ:WILN) manages the intellectual property of third party inventors to ensure they receive fair compensation for their investment in research and development. By enabling patent owners to sell or license patented intellectual property, WiLAN helps provide a financial incentive for inventors to invest in the development of new technologies.
WiLAN has gone through several difficult....More>>>
After a long stretch of calm and a relentless rally, the stock market could be headed for trouble. Stock market corrections, typically defined as a loss between 10% and 20% from the peak, occur about every two years, on average. The last one began in May 2015, so were due. The S&P 500 trades at a
Large cap upscale accessories retailer Coach Inc (NYSE: COH) reported FY17 Q4 and year end earnings before the market opened on Tuesday with shares falling off in premarket trading despite profit doubling. Q4 net sales totaled $1.13 billion versus $1.15 billion in the prior year. Excluding t
Harriet Tubman's fate on the $20 bill may not be as certain as we once thought. Treasury Secretary Steve Mnuchin told CNBC that Tubman's placement on the bill is "not something that I'm focused on at the moment."
According to Doug Mudd, museum director and curator at the Edward C. Rochette Money